Go Back   English Forum Switzerland > Living in Switzerland > Swiss politics/news  
Reply
 
Thread Tools Display Modes
  #1  
Old 25.01.2011, 23:07
cmirsky's Avatar
Forum Veteran
 
Join Date: Aug 2009
Location: Basel CH
Posts: 576
Groaned at 3 Times in 2 Posts
Thanked 1,038 Times in 323 Posts
cmirsky has a reputation beyond reputecmirsky has a reputation beyond reputecmirsky has a reputation beyond reputecmirsky has a reputation beyond reputecmirsky has a reputation beyond repute
Novartis To Pay $470 million To Buy Genoptix

In a deal with implications for independent clinical pathology laboratories, pharmaceutical giant Novartis (NYSE: NVS) announced that it would acquire pathology testing company Genoptix, Inc. (NASDAQ: GXDX). Novartis will pay $470 million in cash to acquire all the shares of Genoptix.
Although the total amount of $470 million to be paid for Genoptix is nearly one-half billion dollars, one financial analyst who quickly responded to the news believes that Novartis did not pay a premium price for Genoptix.

Most pathologists and clinical laboratory managers know that Genoptix offers a range of cancer tests. On its website, Genoptix describes its test menus as tests for “diagnosing cancers, disorders, and subtypes in bone marrow, blood, and lymph nodes, with expertise in the most challenging diagnoses.

http://www.darkdaily.com/novartis-to...enoptix-012511
__________________
I will always remember my friend.... She was truly one of a kind.....
Reply With Quote
  #2  
Old 25.01.2011, 23:25
Guest
 
Posts: n/a
Re: Novartis To Pay $470 million To Buy Genoptix

Quote:
View Post
Although the total amount of $470 million to be paid for Genoptix is nearly one-half billion dollars, one financial analyst who quickly responded to the news believes that Novartis did not pay a premium price for Genoptix.
Well, I don't think I would want anything to do with that particular "one financial analyst" until he invests in a calculator and passes an intensive training course on "how to divid one number by another number then multiply by 100".

Quote:
"The Novartis offer represents a premium of 39% over Genoptix's unaffected share price of USD 17.98 on December 13, 2010. It also implies a 27% premium over the closing price of USD 19.76 on January 21, 2011."
Reply With Quote
  #3  
Old 26.01.2011, 10:26
Nil's Avatar
Nil Nil is offline
Forum Legend
 
Join Date: Sep 2007
Location: Basel
Posts: 10,356
Groaned at 428 Times in 333 Posts
Thanked 16,045 Times in 6,322 Posts
Nil has a reputation beyond reputeNil has a reputation beyond reputeNil has a reputation beyond reputeNil has a reputation beyond reputeNil has a reputation beyond reputeNil has a reputation beyond repute
Re: Novartis To Pay $470 million To Buy Genoptix

That would explain why they are cutting so many positions beside the release of one of their products to generics market....
Reply With Quote
Reply




Currently Active Users Viewing This Thread: 1 (0 members and 1 guests)
 
Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Trackbacks are Off
Pingbacks are Off
Refbacks are Off


Similar Threads
Thread Thread Starter Forum Replies Last Post
Interview @ Novartis dodoGB Employment 18 14.11.2012 13:30
Useful calculator for finding out how much tax you need to pay on 3rd pillar pay out muze7 Finance/banking/taxation 11 20.01.2012 08:37


All times are GMT +2. The time now is 06:12.


Powered by vBulletin® Version 3.8.4
Copyright ©2000 - 2022, Jelsoft Enterprises Ltd.
LinkBacks Enabled by vBSEO 3.1.0